DIM
HARP

DC Investments Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

DC Investments Management’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,444
Closed -$421K – 374
2019
Q1 		$421K Buy
+4,444
New +$584K 0.27% 174

Other funds holding HARP

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DC Investments Management's HARP Position: Q2 2019 in Review

DC Investments Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2019, closing a stake of 4,444 shares — an estimated $421K sold.

DC Investments Management first reported a position in HARP in Q1 2019 and held it in 1 quarter. The position peaked at $421K in Q1 2019. 33 funds tracked by Wall St. Rank hold HARP as of Q2 2019.

  • DC Investments Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • DC Investments Management sold 4,444 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $421K.
  • DC Investments Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • DC Investments Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $421K in Q1 2019.
  • 33 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2019.

Based on DC Investments Management's 13F filing for Q2 2019, filed 12 Aug 2019.